8-KItem 2.02 · Results of OperationsItem 5.02 · Officer/Director ChangeItem 8.01 · Other EventsItem 9.01 · Financial Statements
BAXTER INTERNATIONAL INC (BAX)

Baxter ($BAX) filed an 8‑K on Feb 12, 2026 furnishing a press release (Exhibit 99.1) and an Inline XBRL…

Filed with the SEC on · Summarized by InvestorsBot

Baxter ($BAX) filed an 8‑K on Feb 12, 2026 furnishing a press release (Exhibit 99.1) and an Inline XBRL cover page (Exhibit 104). Press release dated Feb 12, 2026. 📄 #SECfiling #MedTech

The 8‑K was signed Feb 12, 2026 by Joel T. Grade, EVP & CFO. Investors should review the Feb 12 press release (Ex. 99.1) for any material updates. ✍️ $BAX #Investing #Healthcare

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from BAXTER INTERNATIONAL INC

Baxter filed Exhibit 99.1 — "Stockholder Engagement Presentation (2026)" as Item 9.01 on 2026-03-19.

8-K · March 19, 2026

Baxter furnished a presentation (Exhibit 99.1) to certain stockholders on/after Mar 19, 2026 as part of…

8-K · March 19, 2026

Baxter filed an 8‑K on Mar 16, 2026: furnished Exhibit 99.1 (Press Release dated Mar 16, 2026) and Exhibit…

8-K · March 16, 2026

Baxter ($BAX) — Mar 16, 2026: Mr.

8-K · March 16, 2026

Joel Grade ceased as EVP & CFO of Baxter ($BAX) effective Mar 16, 2026 and will serve as a non‑executive…

8-K · March 16, 2026

Baxter ($BAX) Board declared a quarterly cash dividend of $0.01 per share, effective Feb 11, 2026.

8-K · February 12, 2026